Tags

Type your tag names separated by a space and hit enter

Molecular investigation of GB virus C RNA in hemodialysis and thalassemics patients from Brazil.
Ren Fail. 2003 Jan; 25(1):67-75.RF

Abstract

The GB virus C (GBV-C)/hepatitis G virus (HGV) is a member of the Flaviviridae family. Based on the clinical and epidemiological profiles, this virus could be acquired mainly by parenteral transmission through contaminated blood. We therefore investigated the presence of GBV-C/HGV and its relation with the other blood borne viruses as hepatitis B and C viruses (HBV, HCV) in hemodialysis and thalassemic individuals and blood donors from Ribeirão Preto-Brazil. Detection of blood borne virus markers including HBV surface antigen (HbsAg), HBV core antibody (anti-Hbc) and HCV antibody was carried out. HIV-1, HIV-2, HTLV-1 and HTLV-2 were also investigated. GBV-C/HGV RNA was detected by reverse transcriptase and polymerase chain reaction (RT-PCR). Ninety-four serum samples from patients with chronic renal failure were analyzed. GBV-C/HGV RNA was identified in 12 (12.8%) patients, anti-HCV antibodies in 28 (29.8%), anti-Hbc in 9 (9.6%), anti-HIV in 1 (1%), HBsAg in 33 (35.1%), and HBsAg/ anti-HBc was observed in 2 (2.1%) patients. Thirty-six (38.3%) samples were non-reactive. Seven of the 12 GBV-C/HGV RNA infected samples were co-infected with other viruses: 3 (25%) with HBsAg, 2 (16.7%) with anti-HCV and 2 (16.7%) with anti-HBc/anti-HCV/HBsAg. Among the 42 thalassemic patients GBV-C/HGV RNA was detected in 6/42 patients (14.2 %). Three patients presented GBV-C/HGV, with other blood borne markers. We also detected GBV-C/ HGV in 6/50 (12%) blood donors. In these GBV-C/HGV positive thalassemics patients, 50% (3/6) were young individuals (lesser 15 years old) and 67% (4/6) were female patients. The presence of GBV-C RNA in the absence of hepatitis B and C infection in the young patients and healthy donors could be indicate that this virus is capable of independent transmission and does not contribute to liver disease.

Authors+Show Affiliations

Department of Pathological Sciences, Londrina State University, Londrina, PR, Brazil. maewat@sercomtel.com.brNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Clinical Trial
Comparative Study
Journal Article

Language

eng

PubMed ID

12617334

Citation

Watanabe, Maria Angelica Ehara, et al. "Molecular Investigation of GB Virus C RNA in Hemodialysis and Thalassemics Patients From Brazil." Renal Failure, vol. 25, no. 1, 2003, pp. 67-75.
Watanabe MA, Milanezi CM, Silva WA, et al. Molecular investigation of GB virus C RNA in hemodialysis and thalassemics patients from Brazil. Ren Fail. 2003;25(1):67-75.
Watanabe, M. A., Milanezi, C. M., Silva, W. A., de Lucena Angulo, I., Santis, G., Kashima, S., da Costa, J. A., Neto, M. M., & Covas, D. T. (2003). Molecular investigation of GB virus C RNA in hemodialysis and thalassemics patients from Brazil. Renal Failure, 25(1), 67-75.
Watanabe MA, et al. Molecular Investigation of GB Virus C RNA in Hemodialysis and Thalassemics Patients From Brazil. Ren Fail. 2003;25(1):67-75. PubMed PMID: 12617334.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Molecular investigation of GB virus C RNA in hemodialysis and thalassemics patients from Brazil. AU - Watanabe,Maria Angelica Ehara, AU - Milanezi,Cristiane Maria, AU - Silva,Wilson Araújo,Jr AU - de Lucena Angulo,Ivan, AU - Santis,Gil, AU - Kashima,Simone, AU - da Costa,José Abrão Cardeal, AU - Neto,Miguel Moisés, AU - Covas,Dimas Tadeu, PY - 2003/3/6/pubmed PY - 2003/6/13/medline PY - 2003/3/6/entrez SP - 67 EP - 75 JF - Renal failure JO - Ren Fail VL - 25 IS - 1 N2 - The GB virus C (GBV-C)/hepatitis G virus (HGV) is a member of the Flaviviridae family. Based on the clinical and epidemiological profiles, this virus could be acquired mainly by parenteral transmission through contaminated blood. We therefore investigated the presence of GBV-C/HGV and its relation with the other blood borne viruses as hepatitis B and C viruses (HBV, HCV) in hemodialysis and thalassemic individuals and blood donors from Ribeirão Preto-Brazil. Detection of blood borne virus markers including HBV surface antigen (HbsAg), HBV core antibody (anti-Hbc) and HCV antibody was carried out. HIV-1, HIV-2, HTLV-1 and HTLV-2 were also investigated. GBV-C/HGV RNA was detected by reverse transcriptase and polymerase chain reaction (RT-PCR). Ninety-four serum samples from patients with chronic renal failure were analyzed. GBV-C/HGV RNA was identified in 12 (12.8%) patients, anti-HCV antibodies in 28 (29.8%), anti-Hbc in 9 (9.6%), anti-HIV in 1 (1%), HBsAg in 33 (35.1%), and HBsAg/ anti-HBc was observed in 2 (2.1%) patients. Thirty-six (38.3%) samples were non-reactive. Seven of the 12 GBV-C/HGV RNA infected samples were co-infected with other viruses: 3 (25%) with HBsAg, 2 (16.7%) with anti-HCV and 2 (16.7%) with anti-HBc/anti-HCV/HBsAg. Among the 42 thalassemic patients GBV-C/HGV RNA was detected in 6/42 patients (14.2 %). Three patients presented GBV-C/HGV, with other blood borne markers. We also detected GBV-C/ HGV in 6/50 (12%) blood donors. In these GBV-C/HGV positive thalassemics patients, 50% (3/6) were young individuals (lesser 15 years old) and 67% (4/6) were female patients. The presence of GBV-C RNA in the absence of hepatitis B and C infection in the young patients and healthy donors could be indicate that this virus is capable of independent transmission and does not contribute to liver disease. SN - 0886-022X UR - https://www.unboundmedicine.com/medline/citation/12617334/Molecular_investigation_of_GB_virus_C_RNA_in_hemodialysis_and_thalassemics_patients_from_Brazil_ L2 - http://www.tandfonline.com/doi/full/10.1081/jdi-120017469 DB - PRIME DP - Unbound Medicine ER -